Alexander N Meleshko

6PUBLICATIONS

11CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 27, 2026

Correction: Lutskovich et al. Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma. <i>Biomedicines</i> 2025, <i>13</i>, 2130.

|Sep 27, 2025

Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma.

Dzmitry V Lutskovich, Alexander N Meleshko, Valeria M Stepanova

|Nov 29, 2023

CAR-T Cell Therapy for Classical Hodgkin Lymphoma.

Mikalai Katsin, Dmitri Dormeshkin, Alexander Meleshko

|Jul 27, 2022

Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study.

Alexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich

|Jun 29, 2020

Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model.

Maria V Stegantseva, Veronika A Shinkevich, Elena M Tumar

|Nov 17, 2018

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma.

Alexey V Stepanov, Oleg V Markov, Ivan V Chernikov

Pageof 1

Frequent Collaborators

Dmitri O Dormeshkin

Alexandr Migas

Alexey V Stepanov

Daniil V Gladkikh

Roman S Kalinin

Jia Xie

Alexander G Gabibov

Richard A Lerner

Maria V Stegantseva

Veronika A Shinkevich

Frequent Collaborators

Dmitri O Dormeshkin

Alexandr Migas

Alexey V Stepanov

Daniil V Gladkikh